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Results, continued

Results

Introduction

Figure 1

Postmastectomy radiation therapy
(PMRT) following breast reconstruction
is among the leading choices of
treatment in patients with breast cancer.
However, various reconstruction
complications have been linked to this
approach. These include infection,
wound dehiscence, skin flap necrosis,
implant exposure, capsular contracture,
seroma, and hematoma. While some
research has sought to identify potential
covariates, which influence the rate of
complications among this demographic,
there lies a gap in explaining the role of
radiation therapy (RT) on reconstruction
complications among postmastectomy
patients receiving implant-based
reconstruction. Our research aims to
assess the impact of radiation therapy
on reconstruction complications for
patients undergoing implant-based
reconstruction.

COMPLICATION TYPE BREAKDOWN

Table 2

Hematoma
4%

In this study, infection was the most common
reconstruction complication among all patients, followed
by seroma.
Figure 1 illustrates the frequency of each type of
reconstruction complication among the total patients
who faced complications.

Seroma
22%

Infection
34%

Deflation/rupture
4%
Capsular
contracture
2%
Implant exposure
9%
Necrosis
12%

Wound dehiscence
13%

Table 1

Complication

Total, n
(%)

Mastectomy,
no RT, n (%)

Mastectomy RT
+ TE removed, n
(%)

RT with TE
in place, n
(%)

TE after RT,
n (%)

Infection

130 (17.0)

65 (12.2)

14 (70.0)

41 (26.3)

10 (43.5)

Seroma

83 (10.8)

51 (9.6)

6 (30.0)

24 (15.4)

2 (8.7)

Wound
dehiscence

50 (6.5)

33 (6.2)

4 (20.0)

12 (7.7

1 (4.3)

Capsular
contracture

6 (0.8)

4 (0.7)

N/A

1 (0.6)

1 (4.3)

Deflation/ruptur
e

16 (2.1)

13 (2.3)

1 (5.0)

2 (1.3)

0

Necrosis

48 (6.3)

32 (5.7)

4 (20.0)

10 (6.4)

2 (8.7)

Hematoma

16 (2.1)

12 (2.2)

2 (10.0)

2 (1.3)

0

Implant
exposure

34 (4.4)

17 (3.2)

4 (20.0)

10 (6.4)

3 (13.0)

Figure 2

Table 3: Complication rates among all patients
Covariate
Categorical factors
Smoking history
Diabetes mellitus (DM)
Hypertension

The reconstruction complication rate was highest among
patients who underwent TE removal prior to RT and
lowest in patients who underwent mastectomy without RT.
These complication rate differences between category are
statistically significant (P < .001).

Figure 3
Time to Reconstruction Complication by Category

Complication rate with
covariate

Complication rate without
covariate

P value

8/28 (28.6%)
22/49 (44.9%)
64/154 (41.6%)

224/737 (30.4%)
210/716 (29.3%)
168/611 (27.5%)

.000
.022
.001

Intervention
Radiation technique
CW+RNI photon/eVMAT
PWT
All eTangents only
Protons
Boost type
e- skin only, single field/split field
VMAT
Mini tangents
e- to CW, single field/split field
3D photon +/- e- plan

Complication rate

P value
.088

62/133 (46.6%)
4/9 (44.4%)
6/16 (37.5%)
1/2 (50.0%)
7/14 (50.0%)
1/2 (50.0%)
.095
36/88 (41.0%)
1/2 (50.0%)
0
23/53 (43.3%)
2/3 (66.7%)

60%

Materials and Methods

50%

40%

A retrospective cohort study was
conducted in patients who underwent
mastectomy followed by breast
reconstruction from October 2016 to
December 2019. We reviewed charts
from 548 patients undergoing
mastectomy in 765 breasts, who were
planned for immediate delayed implantbased breast reconstruction using tissue
expanders. The identified breasts were
separated into 4 groups:
1.
2.
3.
4.

Postmastectomy reconstruction without
RT (n=566)
Mastectomy with tissue expander (TE)
removed prior to RT (n=20)
Mastectomy with TE in place during RT
(n=156)
TE in prior radiated breast (n=23)

Categorical variables were compared
using the Chi-squared test. P-values
less than 0.05 were considered
statistically significant.

Conclusions

30%

20%

10%

0%
Mastectomy no RT

under 1 month

Mastectomy RT + TE removed

between 1-3 months

Mastectomy RT with TE

between 3-10 months

TE in prior radiated breast

greater than 10 months

In patients who received RT, half of reconstruction complications occurred over 10 months
following the procedure. In contrast, postmastectomy patients who did not receive RT had the
majority (55.2%) of complications take place within one month of the procedure. (P < .001).

Figure 4

Our findings indicate that radiation
therapy in the setting of postmastectomy
breast cancer patients with implantbased breast reconstruction is linked to a
higher reconstruction complication rate
compared to those patients who did not
receive RT. Certain covariates such as
DM and hypertension increase the risk of
complications among this demographic.
Varying the radiation technique does not
influence complication rates.

Future Directions
Figure 4 displays time to
complications by grouping.
Time is indicated in days.

Ongoing research with these data aims to
analyze the effects that different
dosimetric factors and deflation of the
tissue expander has on complication rates
among PMRT patients.

